Vyne Therapeutics Inc (VYNE) earnings · rev $570.0K
These earnings events as JSON? API free 100/dayVyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
This VYNE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VYNE revenue for 2025-12-31 was $570.0K. Net income was -$26.5M. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. VYNE currently screens at market cap $21.1M.
When the next VYNE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 13.8% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VYNE research stays on the stock page; the tape stays on the quote page.
VYNE earnings FAQ
What are VYNE's latest revenue and net income?
Latest cached Vyne Therapeutics Inc (VYNE) revenue for Dec 31, 2025 was $570.0K. Net income was -$26.5M. Statements: https://lician.com/financials/vyne
What is VYNE's latest diluted EPS?
Latest cached Vyne Therapeutics Inc (VYNE) diluted EPS for Dec 31, 2025 was -$0.62.
What period does the latest VYNE earnings print cover?
The latest cached Vyne Therapeutics Inc (VYNE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did VYNE revenue change from the prior cached period?
Cached Vyne Therapeutics Inc (VYNE) revenue was up 13.8% from $501.0K (Dec 31, 2024) to $570.0K (Dec 31, 2025). Statements: https://lician.com/financials/vyne
Where are VYNE earnings listed?
Cached earnings facts for Vyne Therapeutics Inc (VYNE) are listed at https://lician.com/earnings/vyne. Statements: https://lician.com/financials/vyne
Not investment advice.